The influence of N-acetylcysteine on oxidative stress in patients with COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010
Dichloroacetate reduces exercise-induced systemic oxidative stress in COPD Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008
Does oxidative stress diminish after recovery from COPD exacerbation? Source: Eur Respir J 2005; 26: Suppl. 49, 282s Year: 2005
COPD and oxidative stress: NAC‘s (n-acetylcysteine) effects Source: Annual Congress 2007 - Mechanisms and new treatments of COPD Year: 2007
Exercise-induced oxidative stress in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 552s Year: 2003
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008
Effectiveness of N-acetylcysteine in correction of oxidative stress in combined therapy in patients with severe bronchial asthma Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007
Mitochondrial contribution to oxidative stress in the diaphragm of patients with severe COPD Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008
Rosuvastatin effects on systemic inflammation, oxidative stress and antioxidants in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016
Influence of oxygen therapy on oxidative stress parameters in severe COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 234s Year: 2002
The effects of antioxidant therapy on lung clearance, pulmonary function test and oxidant stress in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002
Evaluation of indacaterol and glycopyrronium as inhalation powder on systemic inflammatory and oxidative stress parameters in severe COPD Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016
Four weeks of treatment with n-acetyl cysteine (NAC) (1200mg/day) reduces lung oxidative stress and improves lung function in moderate-to-severe COPD subjects Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
The inflammatory response to high doses of terbutaline during an acute exercise bout in patients with severe COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients Source: Eur Respir J 2002; 20: 1123-1129 Year: 2002
Exercise-induced oxidative stress in COPD before and after rehabilitation Source: Eur Respir J 2004; 24: Suppl. 48, 255s Year: 2004
Oxidative stress and mitochondrial dysfunction in a novel in vivo exacerbation model of severe asthma Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men Year: 2020
The role of oxidative stress in COPD Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling Year: 2008
Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007
8-isoprostane as a marker of oxidant stress in non-symptomatic cigarette smokers and COPD Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation Year: 2006